These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 33776917)

  • 21. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
    Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
    Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
    Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.
    Stefan N; Birkenfeld AL; Schulze MB
    Nat Rev Endocrinol; 2021 Mar; 17(3):135-149. PubMed ID: 33479538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excess body weight is an independent risk factor for severe forms of COVID-19.
    Pietri L; Giorgi R; Bégu A; Lojou M; Koubi M; Cauchois R; Grangeot R; Dubois N; Kaplanski G; Valéro R; Béliard S
    Metabolism; 2021 Apr; 117():154703. PubMed ID: 33421506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet.
    Valerio A; Nisoli E; Rossi AP; Pellegrini M; Todesco T; El Ghoch M
    J Popul Ther Clin Pharmacol; 2020 Jun; 27(S Pt 1):e31-e36. PubMed ID: 32650354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
    Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
    Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interrelations between COVID-19 and other disorders.
    Gasmi A; Peana M; Pivina L; Srinath S; Gasmi Benahmed A; Semenova Y; Menzel A; Dadar M; Bjørklund G
    Clin Immunol; 2021 Mar; 224():108651. PubMed ID: 33333255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.
    Sharma JR; Yadav UCS
    Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus disease 2019 (COVID-19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease.
    Cornejo-Pareja IM; Gómez-Pérez AM; Fernández-García JC; Barahona San Millan R; Aguilera Luque A; de Hollanda A; Jiménez A; Jimenez-Murcia S; Munguia L; Ortega E; Fernandez-Aranda F; Fernández Real JM; Tinahones F
    Eur Eat Disord Rev; 2020 Nov; 28(6):799-815. PubMed ID: 32974994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019.
    Fishkin T; Goldberg MD; Frishman WH
    Cardiol Rev; 2021 Nov-Dec 01; 29(6):292-295. PubMed ID: 34261900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France.
    Hoang VT; Colson P; Levasseur A; Delerce J; Lagier JC; Parola P; Million M; Fournier PE; Raoult D; Gautret P
    Infect Genet Evol; 2021 Nov; 95():105092. PubMed ID: 34571275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 and Cardiovascular Comorbidities.
    Müller-Wieland D; Marx N; Dreher M; Fritzen K; Schnell O
    Exp Clin Endocrinol Diabetes; 2022 Mar; 130(3):178-189. PubMed ID: 33157558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia.
    Holder K; Reddy PH
    Neuroscientist; 2021 Aug; 27(4):331-339. PubMed ID: 32981462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 and cardiovascular disease: a review of current knowledge.
    Pal A; Ahirwar AK; Sakarde A; Asia P; Gopal N; Alam S; Kaim K; Ahirwar P; Sorte SR
    Horm Mol Biol Clin Investig; 2021 Feb; 42(1):99-104. PubMed ID: 33544511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between COVID-19 and obesity.
    Ekiz T; Pazarlı AC
    Diabetes Metab Syndr; 2020; 14(5):761-763. PubMed ID: 32505980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.